Aliso Viejo-based Okami Medical last week announced that it raised an oversubscribed $45 million financing to accelerate commercial expansion and advance its clinical trials.
“I’m honored to join the Okami team and have been deeply impressed by the clinical performance and versatility of the LOBO vascular occluder across a wide range of anatomies,” Chief Executive Drew Hykes said in a statement.
The financing was led by new investor Glide Healthcare with participation from existing investors Vensana Capital and U.S. Venture Partners.
Additionally, Geoff Pardo and Susana Amorim of Glide Healthcare have joined Okami’s board of directors.
